Watch HRGN. Know when insiders buy.
One email the day a filing lands. Free.
HRGN
Harvard Apparatus Regenerative Technology, Inc.
2.35
+0.05 +2.17%
USD · close Sep 17
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
50
WATCH · shorts 50
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $41.3MP/E —DIV YIELD —FCF YIELD —REV TTM $982K +44.6%NET INCOME −$6.7MNET CASH —52W 1.00 – 2.35SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $414K | +30.6% | 5.6% | −$1.7M | −$1.7M | — | -0.10 | −$569K | — | — | Aug 13 |
| Q1 2026 · Mar 31 | $226K | +402.2% | 8.8% | −$1.6M | −$1.6M | — | -0.09 | −$937K | — | — | May 13 |
| Q4 2025 · Dec 31derived | $219K | −15.1% | 9.1% | −$1.7M | −$1.7M | — | -0.10 | −$664K | — | — | Mar 19 |
| Q3 2025 · Sep 30 | $123K | +108.5% | 8.9% | −$1.7M | −$1.7M | — | -0.10 | −$1.5M | — | — | Nov 7 |
| Q2 2025 · Jun 30 | $317K | +466.1% | 4.7% | −$1.8M | −$1.8M | — | -0.11 | −$941K | — | — | Aug 13 |
| Q1 2025 · Mar 31 | $45K | −21.1% | 26.7% | −$1.7M | −$1.7M | — | -0.10 | −$758K | — | — | May 13 |
| Q4 2024 · Dec 31derived | $258K | +309.5% | 32.2% | −$1.4M | −$1.3M | — | -0.08 | −$1.1M | — | — | Mar 19 |
| Q3 2024 · Sep 30 | $59K | +47.5% | -18.6% | −$1.9M | −$1.9M | — | -0.12 | −$1.5M | — | — | Nov 7 |
| Q2 2024 · Jun 30 | $56K | — | 76.8% | −$2.5M | −$2.5M | — | -0.18 | −$1.3M | — | — | Aug 11 |
| Q1 2024 · Mar 31 | $57K | — | 78.9% | −$2M | −$2M | — | -0.15 | −$960K | — | — | May 14 |
| Q4 2023 · Dec 31derived | $63K | — | — | −$1.8M | −$1.8M | — | -0.13 | −$1.2M | $0 | −$1.2M | Mar 31 |
| Q3 2023 · Sep 30 | $40K | — | — | −$1.6M | −$1.6M | — | -0.12 | −$3.2M | $0 | −$3.2M | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $704K | 8.2% | −$6.9M | −$6.9M | -975.7% | -0.42 | −$3.8M | — | — | — | — |
| FY2024 · to Dec 31 | $430K | 37.2% | −$7.7M | −$7.7M | -1798.1% | -0.52 | −$4.9M | $0 | −$4.9M | — | — |
| FY2023 · to Dec 31 | $103K | 76.7% | −$9M | −$8.9M | -8684.5% | -0.67 | −$6.9M | $11K | −$7M | — | — |
| FY2022 · to Dec 31 | — | — | −$6.2M | −$6.1M | — | -0.55 | −$5.1M | $5K | −$5.1M | — | — |
| FY2021 · to Dec 31 | $0 | — | −$8.6M | −$8M | — | -0.79 | −$2.6M | $0 | −$2.6M | $0 | — |
| FY2020 · to Dec 31 | $0 | — | −$5.3M | −$4.9M | — | -0.55 | −$4M | $7K | −$4M | $42K | — |
Every number comes from Harvard Apparatus Regenerative Technology, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.